Individualized Diets, ALCAT and BMJ Gastroentorology

This week’s historic podcast: “Individualized Diets, ALCAT, and BMJ Gastroenterology” features the results of a brand-new study published in the British Medical Journal, validating food sensitivity testing (the ALCAT Test®) for IBS patients.

The study named, “Efficacy of Individualized Diets in Patients with Irritable Bowel Syndrome: A Randomized Control Trial” was led by the late Dr. Ather Ali, ND a colleague of our co-founder, James Maskell, who sadly passed away this October.

It is our great pleasure to honor Dr. Ali’s legacy by helping spread the word about his incredible research.

In this podcast, James interviews another of the study’s lead researchers: Dr. Wajahat Mehal, professor of medicine at Yale University, for the inside scoop on this ground-breaking study.

Tune in today to get all the details direct from the source, including:

• A high-level overview of the entire randomized, controlled, blinded study from Dr. Mehal
• An inside-look at key outcomes of the study, including significant improvements in the Global Improvement Scale (GIS) at 4 weeks and 8 weeks for IBS patients who specifically removed Alcat positive food items from their diet
• Dr. Mehal’s take on the most encouraging results of the study
• Insights on the implications of this study to the future of gastroenterology and functional medcine